Excellent find. I liked this part. Was going to buy a little more Geron today but I don't think so now.
"Meanwhile, ACT believes it has stolen a march on Geron because its own pre-clinical studies on animals have shown that its embryonic stem cells are extremely pure and safe with no signs of the cysts seen in the animals injected with the embryonic stem cells that Geron was hoping to use in patients suffering from spinal cord injuries. "They've been through this with Geron and the company has put out an announcement that they won't start until the third quarter of next year, so ours may well be the first trial," Dr Lanza said."
I am not worried about dilution and all the other nonsense posted here recently. In at .06 and believe strongly in this company in the long run. I think the past year has been spent communicating with the FDA and getting their financial house in order. Sure, we didn't see a pop yesterday but the volume was huge and going to grow. it will come and that run to .29 for no reason will seem like a silly memory.
And, they are using their core technology here. I don't care about what happens to embryos that are just going in the trash anyway, but some people do.
"A single cell from a human embryo left over from IVF treatment was used in the creation of the stem cell "line" that Dr Lanza and his colleagues cultivated in the laboratory. By bathing the stem cells in a suite of chemical messengers, they were able to stimulate them to develop into fully mature retinal pigment epithelium cells."